Detalles de la búsqueda
1.
The evolution of non-small cell lung cancer metastases in TRACERx.
Nature;
616(7957): 534-542, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37046095
2.
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature;
585(7826): E21, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32887973
3.
The National Lung Matrix Trial of personalized therapy in lung cancer.
Nature;
583(7818): 807-812, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32669708
4.
The Effects of GCSF Primary Prophylaxis on Survival Outcomes and Toxicity in Patients with Advanced Non-Small Cell Lung Cancer on First-Line Chemoimmunotherapy: A Sub-Analysis of the Spinnaker Study.
Int J Mol Sci;
24(2)2023 Jan 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36675262
5.
Analysis of Immune Landscape in Pancreatic and Ileal Neuroendocrine Tumours Demonstrates an Immune Cold Tumour Microenvironment.
Neuroendocrinology;
112(4): 370-383, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34157710
6.
Large cell neuroendocrine lung carcinoma: consensus statement from The British Thoracic Oncology Group and the Association of Pulmonary Pathologists.
Br J Cancer;
125(9): 1210-1216, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34489586
7.
Towards personalised medicine in lung and thymus neuroendocrine tumours.
Lancet Oncol;
18(12): 1563-1565, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074101
8.
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis.
Front Oncol;
13: 1163768, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37324003
9.
Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres.
BMJ Open;
13(11): e073120, 2023 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37993149
10.
NET-02: a randomised, non-comparative, phase II trial of nal-IRI/5-FU or docetaxel as second-line therapy in patients with progressive poorly differentiated extra-pulmonary neuroendocrine carcinoma.
EClinicalMedicine;
60: 102015, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287870
11.
A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancer.
Chemotherapy;
58(4): 257-63, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22907396
12.
Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis.
BMJ Open;
12(3): e041961, 2022 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241462
13.
Efficacy outcomes and prognostic factors from real-world patients with advanced non-small-cell lung cancer treated with first-line chemoimmunotherapy: The Spinnaker retrospective study.
Int Immunopharmacol;
110: 108985, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35777264
14.
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinations.
J Immunother Cancer;
10(2)2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173031
15.
NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC).
BMJ Open;
10(2): e034527, 2020 02 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32029495
16.
Easing the transition from student to doctor: how can medical schools help prepare their graduates for starting work?
Med Teach;
31(5): 403-8, 2009 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-19142797
17.
Twelve tips for studying medical education at doctoral level.
Med Teach;
31(7): 601-4, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19811145
18.
The utility of Ki-67 as a prognostic biomarker in pulmonary neuroendocrine tumours: protocol for a systematic review and meta-analysis.
BMJ Open;
9(8): e031531, 2019 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-31446421
19.
Recent advances in the molecular landscape of lung neuroendocrine tumors.
Expert Rev Mol Diagn;
19(4): 281-297, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30900485
20.
DR WHO: a workshop for house officer preparation.
Postgrad Med J;
83(975): 4-7, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17267671